title: Immune Class Regulation and Its Medical Significance Part II of a Report of a Workshop on Foundational Concepts of Immune Regulation.
abstract: We discussed different proposals for how the nature of the Th1/Th2 phenotype of an immune response is determined, and favoured one, the Threshold Hypothesis, as plausible and so useful as the basis for further discussions. The activation of a target CD4 T cell can be facilitated by helper CD4 T cells when the CD4 T cells interact via an antigen-presenting cell. The Threshold Hypothesis states that tentative and robust antigen-mediated CD4 T cell cooperation results in the target CD4 T cell, respectively giving rise, upon activation, to Th1 and Th2 cells. We primarily discussed four topics. We briefly discussed in the background section certain limitations of the Th1/Th2 paradigm in understanding immune class regulation, and the remarkable anti-inflammatory properties of human IgG4antibody. Secondly, we assessed the role of class II MHC molecules in determining the number of mature CD4 T cells and so affecting the Th1/Th2 phenotype of immune responses. We also discussed the controversial role of CD8 T cells in affecting the Th1/Th2 phenotype of responses to MHC and other antigens, and the potential role of their relative scarcity in neonates in biasing responses towards an antibody, Th2 mode. Lastly, we examined the regulation of the Th1/Th2 phenotype of both primary and ongoing immune responses in the context of the intriguing proposal that antigen initially generates different classes/subclasses of immunity and then selects, by a feedback mechanism, the most effective class. We found this interesting idea difficult to reconcile with various observations.
authors.affiliation: University of Saskatchewan, Saskatchewan, Canada.
authors.forename: P A
authors.identifier: http://orcid.org/0000-0002-9156-9846
authors.initials: PA
authors.lastname: Bretscher
authors.affiliation: Oslo University Hospital, Oslo, Norway.
authors.forename: A
authors.initials: A
authors.lastname: Corthay
authors.affiliation: University of Alberta, Alberta, Canada.
authors.forename: C C
authors.initials: CC
authors.lastname: Anderson
authors.affiliation: University of Oslo, Oslo, Norway.
authors.forename: Z
authors.initials: Z
authors.lastname: Dembic
authors.affiliation: University of Saskatchewan, Saskatchewan, Canada.
authors.forename: C
authors.initials: C
authors.lastname: Havele
authors.affiliation: Dr.ZAN Pharma Research Consulting, Wolfratshausen, Germany.
authors.forename: Z A
authors.initials: ZA
authors.lastname: Nagy
authors.affiliation: Oslo University Hospital, Oslo, Norway.
authors.forename: I
authors.initials: I
authors.lastname: Øynebråten
mesh_terms: D000938:Antigen-Presenting Cells / Q000276:immunology*; D000941:Antigens / Q000276:immunology*; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D000949:Histocompatibility Antigens Class II / Q000276:immunology; D006801:Humans; D008213:Lymphocyte Activation / Q000276:immunology*; D018417:Th1 Cells / Q000276:immunology*; D018418:Th2 Cells / Q000276:immunology*
chemical_list: D000941:Antigens; D000949:Histocompatibility Antigens Class II